No 02 2017

Returning to work after a long, relaxing vacation can be challenging. Here are some tips to make the transition easier and less stressful.

AlzeCure Pharma has now received the full upfront payment of USD 12 million from the Danish biotech company QuantumCell.

Zealand Pharma has entered into a royalty purchase and sale agreement with Royalty Pharma in exchange for Zealand Pharma’s economics related to rusfertide (PTG-300), a potential first-in-class therapy for polycythemia vera, a rare and chronic blood disorder.

The U.S. Department of Veterans Affairs (VA) Strategic Acquisition Center has awarded a five-year national Non-Expendable Equipment (NX EQ) contract for quantitative neuromuscular monitoring to TrillaMed, LLC, the authorized U.S. federal distributor of the Senzime TetraGraph system.

Researchers at the University of Gothenburg and their international colleagues have identified a seven-protein panel that could improve blood-based testing for Alzheimer’s disease.

Moberg Pharma has announced changes to its management team and strengthens the organization ahead of upcoming launches.

Sweden has retained its position as the European Union’s most innovative member state, while Denmark ranks second, according to the European Commission’s European Innovation Scoreboard 2026.